Emerging clinical initiatives in pharmaceutical development: methodology and regulatory perspectives
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Biopharmaceutical Statistics"
DOI: 10.1080/10543406.2022.2080699
Abstract: This special issue is dedicated to Duke-Industry Statistics Symposium (DISS) 2021, which was organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine and co-sponsored by Amgen, ASA-NC Chapter, Boehringer-Ingelheim, Genentech, ICSA,… read more here.
Keywords: regulatory perspectives; methodology; development; methodology regulatory ... See more keywords